Lifestyle
- Regular physical exercise
- Stress management techniques
- Adequate sleep
Mean Platelet Volume · Mittleres Plättchenvolumen
Mean Platelet Volume (MPV) quantifies the average size of platelets in the blood.
Reference ranges may vary slightly based on laboratory methods and population demographics.
Mean Platelet Volume (MPV) is a measurement that reflects the average size of platelets in the blood. It is a key indicator of platelet function and is often used to assess platelet activation and reactivity. Biologically, MPV is influenced by the rate of platelet production in the bone marrow and the rate of platelet destruction or consumption in the bloodstream. Clinically, MPV is significant as it can indicate various pathological conditions. Elevated MPV levels have been associated with increased platelet activation, which is a risk factor for cardiovascular diseases such as coronary artery disease and preeclampsia. It is also observed in conditions like ADHD and periodontitis, suggesting a link between platelet reactivity and systemic inflammation. In the context of athletic performance and biohacking, MPV may be relevant as it could reflect underlying inflammatory processes or cardiovascular risk, which are important for optimizing health and longevity. However, the interpretation of MPV must consider potential confounders such as acute infections, recent physical activity, and environmental exposures. Time-of-day variations and fasting status do not significantly affect MPV measurements, but consistent testing conditions are recommended for accurate longitudinal tracking.
Klinische Bedeutung
Elevated MPV values indicate increased platelet activation and are associated with higher risk for cardiovascular diseases and systemic inflammation. Reduced MPV may suggest bone marrow suppression or platelet production issues.
Progressively rising MPV values suggest increased platelet activation and potential cardiovascular risk. Re-test in 3-6 months if values are outside the optimal range.
Progressively falling MPV values may indicate improved platelet function or resolution of an inflammatory condition.
Re-test Interval
3-6 months if outside optimal range
Note:
Consult a healthcare provider before making significant lifestyle or dietary changes, especially if underlying health conditions are present.
MPV may vary slightly throughout the day; consistency in testing time is recommended.
Testing Frequency
Annually for routine health assessments, more frequently if monitoring specific conditions.
Current research suggests that reference ranges for mean platelet volume (MPV) in various clinical contexts, such as ADHD and preeclampsia, remain debated, particularly regarding confounders like inflammation and thrombocytopenia. Researchers have not yet established optimal MPV targets for predicting cardiovascular risk or disease severity in conditions like periodontitis. Additionally, clinical questions remain unanswered about the mechanistic pathways linking MPV alterations to specific diseases and the potential role of environmental factors in these associations.
1,265
Total Citations
38
Human/RCT
2.7
Avg. Influence
2026
Latest
Korniluk Aleksandra, et al. · Mediators of inflammation · 2019
Researchers reviewed literature on mean platelet volume (MPV) as a biomarker in inflammatory and neoplastic diseases. They found that increased MPV is associated with various conditions, including cardiovascular diseases and cancers, while decreased MPV is noted in certain inflammatory states. The study emphasizes the potential of MPV in predicting disease progression and outcomes.
Key findings
Researchers investigated the relationship between mean platelet volume (MPV) and mortality in COVID-19 patients. They found that an increase in MPV was associated with higher mortality rates, suggesting that MPV may serve as an auxiliary test for predicting outcomes in COVID-19.
This review focused on the potential of mean platelet volume (MPV) and immature platelet fraction (IPF) as biomarkers in autoimmune disorders. Researchers noted that while MPV has been associated with various diseases, the results in autoimmune conditions remain controversial and require standardization.
This systematic review found that mean platelet volume (MPV) was significantly increased in women with preeclampsia compared to those without. Researchers highlighted MPV as a promising biomarker for evaluating platelet function in preeclampsia, although further studies are needed to confirm its predictive value.
This review focused on mean platelet volume (MPV) as a potential biomarker for heart disease risk and prognosis. Researchers highlighted that MPV may predict ischemic stroke risk in atrial fibrillation patients and guide treatment decisions in coronary artery disease, emphasizing its clinical relevance.
Researchers investigated the clinical significance of platelet-to-lymphocyte ratio (PLR) and mean platelet volume (MPV) in women with preeclampsia. They found that while PLR was a better predictor of preeclampsia severity, MPV and PDW levels differed significantly between women with mild and severe cases.
This study examined the relationship between mean platelet volume (MPV) and disease activity in adults with systemic lupus erythematosus (SLE). Researchers found that MPV was significantly lower in patients with active disease compared to those with inactive disease. Additionally, MPV showed a positive correlation with albumin levels, another marker of disease activity.
This study explored the role of platelet indices, including mean platelet volume (MPV), as prognostic indicators in sepsis. Researchers found that changes in MPV were associated with mortality, suggesting that MPV could be a useful marker for predicting outcomes in septic patients.
Researchers studied the relationship between mean platelet volume (MPV) and coagulation parameters in patients with acute pancreatitis. They found that MPV was significantly higher in patients at admission compared to controls, indicating a potential link between elevated MPV and hypercoagulation in pancreatitis.
This meta-analysis assessed mean platelet volume (MPV) differences in women with preeclampsia compared to healthy pregnant women. Researchers found that MPV was significantly higher in preeclamptic women, particularly in severe cases, indicating its potential as a biomarker for detecting and monitoring preeclampsia.
9
Total Trials
1,631
Total Enrolled
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
425
2026
Intensive Care Unit (ICU) Mortality
Assiut University
200
2026
Mean Platelet Volume (MPV)
Esraa Hamdy Thabit Riad
80
2025
HBP levels in survivors and non survivors patients of VAP measured by ng\ ml using ElISAImmunoassay
Assiut University
170
2024
neutrophil / lymphocyte ratio
Sohag University
100
2024
Evaluate the hematological indices as (mean platelet volume) of our SLE patient.
Cairo University
80
2020
Salivary c reactive protein in neonatal sepsis
Gangnam Severance Hospital
334
2020
The incidence of postoperative 1-yr mortality
Rania Hassan Mostafa
140
2019
Mean Platelet Volume (MPV)
Isfahan University of Medical Sciences
102
2016
MPV in patients and controls
Research publications about MPV over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer